BLAC
Price:
$10.825
Market Cap:
$43.75M
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp. was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.[Read more]
Industry
Shell Companies
IPO Date
2023-03-21
Stock Exchange
NASDAQ
Ticker
BLAC
According to Bellevue Life Sciences Acquisition Corp.’s latest financial reports and current stock price. The company's current PE Ratio is -270.62. This represents a change of 279.68% compared to the average of -71.27 of the last 4 quarters.
The mean historical PE Ratio of Bellevue Life Sciences Acquisition Corp. over the last ten years is -7499.16. The current -270.62 PE Ratio has changed 260.87% with respect to the historical average. Over the past ten years (40 quarters), BLAC's PE Ratio was at its highest in in the September 2023 quarter at 301.13. The PE Ratio was at its lowest in in the September 2021 quarter at -168262.61.
Average
-7499.16
Median
-2965.48
Minimum
-24211.91
Maximum
146.22
Discovering the peaks and valleys of Bellevue Life Sciences Acquisition Corp. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 623.48%
Maximum Annual PE Ratio = 146.22
Minimum Annual Increase = -105.66%
Minimum Annual PE Ratio = -24211.91
Year | PE Ratio | Change |
---|---|---|
2023 | 146.22 | -105.66% |
2022 | -2584.36 | -89.33% |
2021 | -24211.91 | 623.48% |
The current PE Ratio of Bellevue Life Sciences Acquisition Corp. (BLAC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8883.35
5-year avg
-7499.16
10-year avg
-7499.16
Bellevue Life Sciences Acquisition Corp.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellevue Life Sciences Acquisition Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bellevue Life Sciences Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Bellevue Life Sciences Acquisition Corp.'s PE Ratio?
How is the PE Ratio calculated for Bellevue Life Sciences Acquisition Corp. (BLAC)?
What is the highest PE Ratio for Bellevue Life Sciences Acquisition Corp. (BLAC)?
What is the 3-year average PE Ratio for Bellevue Life Sciences Acquisition Corp. (BLAC)?
What is the 5-year average PE Ratio for Bellevue Life Sciences Acquisition Corp. (BLAC)?
How does the current PE Ratio for Bellevue Life Sciences Acquisition Corp. (BLAC) compare to its historical average?